ALSTRIA OFFICE REIT-AG/ DE000A0LD2U1 /
2024-03-28 9:16:25 AM | Chg. -0.0450 | Volume | Bid8:06:39 PM | Ask8:06:39 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3.4100EUR | -1.30% | 0 Turnover: 0.0000 |
3.3250Bid Size: 310 | 3.4550Ask Size: 290 | 607.09 mill.EUR | 1.17% | 2.89 |
GlobeNewswire
10:05 PM
Wintrust Wins Highest Ranking by J.D. Power for Illinois Retail Banking Customer Satisfaction for th...
GlobeNewswire
10:00 PM
Cielo Announces Fiscal Q3 2024 Financial Results and Provides Update on its Progress to Fuel Renewab...
GlobeNewswire
10:00 PM
Aimfinity Investment Corp. I Announces Eighth Extension of the Deadline for an Initial Business Comb...
GlobeNewswire
10:00 PM
Western Forest Products Inc. Announces Release Date of First Quarter 2024 Results and Conference Cal...
GlobeNewswire
9:59 PM
Nilam Resources, Inc. Appoints Pranjali More as Interim Chief Executive Officer, Updates the Market ...
GlobeNewswire
9:51 PM
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
9:45 PM
Bitdeer Reports Financial Results for the Full Year 2023 and Operational Update
GlobeNewswire
9:34 PM
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
9:32 PM
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
GlobeNewswire
9:30 PM
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatmen...
GlobeNewswire
9:30 PM
Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Beha...
GlobeNewswire
9:28 PM
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter an...